Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
cBA821CXhmy7wtGb